Citation Impact
Citing Papers
Secondary BRCA1 Mutations in BRCA1 -Mutated Ovarian Carcinomas with Platinum Resistance
2008
Development of a Functional Assay for Homologous Recombination Status in Primary Cultures of Epithelial Ovarian Tumor and Correlation with Sensitivity to Poly(ADP-Ribose) Polymerase Inhibitors
2010
Decitabine Enhances Lymphocyte Migration and Function and Synergizes with CTLA-4 Blockade in a Murine Ovarian Cancer Model
2015
PARP inhibitors: Synthetic lethality in the clinic
2017 StandoutScience
Comprehensive molecular portraits of human breast tumours
2012 StandoutNature
Mutational landscape and significance across 12 major cancer types
2013 StandoutNature
Long noncoding RNAs in cancer: mechanisms of action and technological advancements
2016
Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities
2008
Cancer treatment and survivorship statistics, 2022
2022 Standout
Interleukin-12: A Cytokine at the Interface of Inflammation and Immunity
1998
Surface-enhanced Raman scattering detection of lysophosphatidic acid
2005
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes
2013 Standout
Targeting hypoxia in cancer therapy
2011 Standout
The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies
2002 Standout
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial
2014
Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
2015 Standout
Epidemiology of Ovarian Cancer
2008
MuSiC: Identifying mutational significance in cancer genomes
2012
Pancreatic cancer
2020 Standout
Interleukin-12 and the regulation of innate resistance and adaptive immunity
2003 Standout
Ovarian cancer
2014 Standout
Lipopolysaccharide sensing an important factor in the innate immune response to Gram-negative bacterial infections: Benefits and hazards of LPS hypersensitivity
2008 StandoutNobel
Pancreatic cancer
2016 Standout
Nrf2, the master redox switch: The Achilles' heel of ovarian cancer?
2014
Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management
2009
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors
2019 Standout
The Human Plasma Lipidome
2011
Current Management Strategies for Ovarian Cancer
2007
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
2010 Standout
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
The natural history of incidentally detected small renal masses
2004
Novel bioactive glycerol-based lysophospholipids: New data – New insight into their function
2012
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results
2011 Standout
Mice lacking tartrate‐resistant acid phosphatase (Acp 5) have disordered macrophage inflammatory responses and reduced clearance of the pathogen, Staphylococcus aureus
2001 StandoutNobel
A review of PARP inhibitors: from bench to bedside
2010
Continent cutaneous urinary diversion: long-term follow-up of more than 800 patients with ileocecal reservoirs
2006
Inherited Pancreatic Cancer Syndromes
2012
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
2010 Standout
Cisplatin: The first metal based anticancer drug
2019 Standout
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
2012 Standout
Nanoceria: A Rare-Earth Nanoparticle as a Novel Anti-Angiogenic Therapeutic Agent in Ovarian Cancer
2013
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
2010 Standout
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
2009 Standout
Association Between <emph type="ital">BRCA1</emph> and <emph type="ital">BRCA2</emph> Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer
2012
Maftools: efficient and comprehensive analysis of somatic variants in cancer
2018 Standout
Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry
2011 Standout
Burch procedure compared with sling for stress urinary incontinence: a decision analysis
2000
Population BRCA1 and BRCA2 Mutation Frequencies and Cancer Penetrances: A Kin–Cohort Study in Ontario, Canada
2006
BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
2012
[Transobturator urethral suspension: mini-invasive procedure in the treatment of stress urinary incontinence in women].
2001 Standout
Raman Spectroscopy of Biological Tissues
2007 Standout
Secondary Somatic Mutations RestoringBRCA1/2Predict Chemotherapy Resistance in Hereditary Ovarian Carcinomas
2011
Inferring tumour purity and stromal and immune cell admixture from expression data
2013 Standout
Neanderthal ancestry drives evolution of lipid catabolism in contemporary Europeans
2014 StandoutNobel
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer
2012
Current Management Strategies for Ovarian Cancer
2007
Hierarchically porous materials: synthesis strategies and structure design
2016 Standout
Ovarian cancer statistics, 2018
2018 Standout
Ovarian Cancer Prevention in High-risk Women
2017
Gene Expression Profile of BRCAness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer
2010
Preventing Future Cancers by Testing Women With Ovarian Cancer forBRCAMutations
2009
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
2016 Standout
Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Cardiovascular Epidemiology and Genetics
2015 Standout
On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1
2012 Standout
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
Metal–organic frameworks: functional luminescent and photonic materials for sensing applications
2017 Standout
International patterns and trends in ovarian cancer incidence, overall and by histologic subtype
2017
Cancer treatment and survivorship statistics, 2016
2016 Standout
Results of Annual Screening in Phase I of the United Kingdom Familial Ovarian Cancer Screening Study Highlight the Need for Strict Adherence to Screening Schedule
2012
Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes
2013
Cancer treatment and survivorship statistics, 2019
2019 Standout
Phospholipid capture combined with non-linear chromatographic correction for improved serum metabolite profiling
2006
Guideline for Management of the Clinical T1 Renal Mass
2009 Standout
A Mixed-Crystal Lanthanide Zeolite-like Metal–Organic Framework as a Fluorescent Indicator for Lysophosphatidic Acid, a Cancer Biomarker
2015
Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives
2015 Standout
Works of Mitchell Hoffman being referenced
Interleukin-12-Mediated Tumoricidal Activity of Patient Lymphocytes in an Autologous in Vitro Ovarian Cancer Assay System
1995
Bladder perforation in a patient with recurrent epithelial ovarian cancer after treatment with bevacizumab
2010
BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases
2005
Urethral obstruction after anti-incontinence surgery in women: Evaluation, methodology, and surgical results
1996
Lysophospholipids Are Potential Biomarkers of Ovarian Cancer
2004
Continent Colonic Urinary Reservoir (Florida Pouch): Long-Term Surgical Complications (Greater Than 11 Years)
2003
Continent colonic urinary reservoir (Florida pouch): long-term surgical complications (greater than 11 years).
2003